Shopping Cart
- Remove All
- Your shopping cart is currently empty
NSC16168 is a selective ERCC1-XPF inhibitor that inhibits DNA repair and potentiates the antitumor activity of cisplatin.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | 423 € | In Stock | |
25 mg | 1.358 € | In Stock | |
50 mg | 1.767 € | In Stock | |
100 mg | 2.375 € | In Stock |
Description | NSC16168 is a selective ERCC1-XPF inhibitor that inhibits DNA repair and potentiates the antitumor activity of cisplatin. |
Targets&IC50 | ERCC1 XPF:0.42 μM |
In vitro | NSC16168 is a specific inhibitor of ERCC1-XPF with an IC50 of 0.42 μM. NSC16168 potentiates the antitumor effect of cisplatin on cancer cells in the concentration range of 0-50 μM. [1] |
In vivo | In the H460 lung cancer xenograft model, NSC16168 was injected intraperitoneally twice a day at a dose of 20 mg/kg and showed significant antitumor effects and synergistically enhanced the efficacy of cisplatin. [1] |
Alias | NSC 16168 |
Molecular Weight | 473.5 |
Formula | C17H15NO9S3 |
Cas No. | 6837-93-0 |
Smiles | O=S(=O)(O)C=1C=C(OS(=O)(=O)C2=CC=C(C=C2)C)C3=C(N)C=C(C=C3C1)S(=O)(=O)O |
Relative Density. | 1.5197 g/cm3 (Estimated) |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 20 mg/mL (42.24 mM), Sonication is recommended | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.